Evidence map›Paper›PMID 35714648›Full record

ArticleThe Lancet. Global health2022

Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project.

Denise O Garrett, Ashley T Longley, Kristen Aiemjoy, Mohammad T Yousafzai, Caitlin Hemlock, Alexander T Yu, Krista Vaidya, Dipesh Tamrakar, Shampa Saha, Isaac I Bogoch and 34 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet. Global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Estimating enteric fever seroincidence in Bangladesh using rapid serosurveys.medRxiv : the preprint server for health sciences · 2026
    Article
  17. Coinfection ofCase reports in infectious diseases · 2026
    Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors at 16 institutions in 9 countries.

Denise O GarrettApplied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA. Electronic address: denise.garrett@sabin.org.
Ashley T LongleyNational Foundation for the Centers for Disease Control and Prevention, Atlanta, GA, USA; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kristen AiemjoyDepartment of Public Health Sciences, University of California Davis, Davis, CA, USA.
Mohammad T YousafzaiDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Caitlin HemlockApplied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA.
Alexander T YuDivision of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
Krista VaidyaDhulikhel Hospital, Kathmandu University Hospital, Kavrepalanchok, Nepal.
Dipesh TamrakarDhulikhel Hospital, Kathmandu University Hospital, Kavrepalanchok, Nepal.
Shampa SahaChild Health Research Foundation, Dhaka, Bangladesh.
Isaac I BogochDepartment of Medicine, University of Toronto, Toronto, ON, Canada.
Kashmira DateGlobal Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Senjuti SahaChild Health Research Foundation, Dhaka, Bangladesh.
Mohammad Shahidul IslamChild Health Research Foundation, Dhaka, Bangladesh.
K M Ishtiaque SayeedChild Health Research Foundation, Dhaka, Bangladesh.
Caryn BernDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Sadia ShakoorDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan; Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.
Irum F DehrajDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Junaid MehmoodDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Mohammad S I SajibChild Health Research Foundation, Dhaka, Bangladesh.
Maksuda IslamChild Health Research Foundation, Dhaka, Bangladesh.
Rozina S ThobaniDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Aneeta HotwaniDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Najeeb RahmanDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Seema IrfanDepartment of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.
Shiva R NagaDhulikhel Hospital, Kathmandu University Hospital, Kavrepalanchok, Nepal.
Ashraf M MemonKharadar General Hospital, Karachi, Pakistan.
Sailesh PradhanKathmandu Medical College Teaching Hospital, Kathmandu, Nepal.
Khalid IqbalKharadar General Hospital, Karachi, Pakistan.
Rajeev ShresthaDhulikhel Hospital, Kathmandu University Hospital, Kavrepalanchok, Nepal.
Hafizur RahmanChild Health Research Foundation, Dhaka, Bangladesh.
Md Mahmudul HasanChild Health Research Foundation, Dhaka, Bangladesh.
Saqib H QaziDepartment of Surgery, Aga Khan University, Karachi, Pakistan.
Abdul M KaziDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Nasir S SaddalNational Institute of Child Health, Karachi, Pakistan.
Raza JamalNational Institute of Child Health, Karachi, Pakistan.
Mohammed J HunzaiDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Tanvir HossainMaternal and Child Health Division, icddr,b, Dhaka, Bangladesh.
Florian MarksInternational Vaccine Institute, Seoul, South Korea; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, UK; University of Antananarivo, Antananarivo, Madagascar; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
Alice S CarterApplied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA.
Jessica C SeidmanApplied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA.
Farah N QamarDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Samir K SahaChild Health Research Foundation, Dhaka, Bangladesh; Bangladesh Institute of Child Health, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Jason R AndrewsDivision of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
Stephen P LubyDivision of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
Aga Khan University · PKChild Health Research Foundation · BDSabin Vaccine Institute · USKathmandu University · NPStanford University · USKharadar General Hospital · PKNational Institute of Child Health · PKCenters for Disease Control and Prevention · USDhulikhel Hospital · NPInternational Centre for Diarrhoeal Disease Research · BDKathmandu Medical College Teaching Hospital · NPThe Centers · USUniversity Hospital Heidelberg · DEUniversity of California, Davis · USUniversity of California, San Francisco · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrecise enteric fever disease burden data are needed to inform prevention and control measures, including the use of newly available typhoid vaccines. We established the Surveillance for Enteric Fever in Asia Project (SEAP) to inform these strategies.

methodsFrom September, 2016, to September, 2019, we conducted prospective clinical surveillance for Salmonella enterica serotype Typhi (S Typhi) and Paratyphi (S Paratyphi) A, B, and C at health facilities in predetermined catchment areas in Dhaka, Bangladesh; Kathmandu and Kavrepalanchok, Nepal; and Karachi, Pakistan. Patients eligible for inclusion were outpatients with 3 or more consecutive days of fever in the last 7 days; inpatients with suspected or confirmed enteric fever; patients with blood culture-confirmed enteric fever from the hospital laboratories not captured by inpatient or outpatient enrolment and cases from the laboratory network; and patients with non-traumatic ileal perforation under surgical care. We used a hybrid surveillance model, pairing facility-based blood culture surveillance with community surveys of health-care use. Blood cultures were performed for enrolled patients. We calculated overall and age-specific typhoid and paratyphoid incidence estimates for each study site. Adjusted estimates accounted for the sensitivity of blood culture, the proportion of eligible individuals who consented and provided blood, the probability of care-seeking at a study facility, and the influence of wealth and education on care-seeking. We additionally calculated incidence of hospitalisation due to typhoid and paratyphoid.

findingsA total of 34 747 patients were enrolled across 23 facilitates (six tertiary hospitals, surgical wards of two additional hospitals, and 15 laboratory network sites) during the study period. Of the 34 303 blood cultures performed on enrolled patients, 8705 (26%) were positive for typhoidal Salmonella. Adjusted incidence rates of enteric fever considered patients in the six tertiary hospitals. Adjusted incidence of S Typhi, expressed per 100 000 person-years, was 913 (95% CI 765-1095) in Dhaka. In Nepal, the adjusted typhoid incidence rates were 330 (230-480) in Kathmandu and 268 (202-362) in Kavrepalanchok. In Pakistan, the adjusted incidence rates per hospital site were 176 (144-216) and 103 (85-126). The adjusted incidence rates of paratyphoid (of which all included cases were due to S Paratyphi A) were 128 (107-154) in Bangladesh, 46 (34-62) and 81 (56-118) in the Nepal sites, and 23 (19-29) and 1 (1-1) in the Pakistan sites. Adjusted incidence of hospitalisation was high across sites, and overall, 2804 (32%) of 8705 patients with blood culture-confirmed enteric fever were hospitalised.

interpretationAcross diverse communities in three south Asian countries, adjusted incidence exceeded the threshold for "high burden" of enteric fever (100 per 100 000 person-years). Incidence was highest among children, although age patterns differed across sites. The substantial disease burden identified highlights the need for control measures, including improvements to water and sanitation infrastructure and the implementation of typhoid vaccines.

fundingBill & Melinda Gates Foundation.

Indexed as

Paratyphoid FeverTyphoid FeverTyphoid-Paratyphoid VaccinesBangladeshChildHumansIncidenceNepalPakistanProspective StudiesSalmonellaSalmonella paratyphi ATyphoid-Paratyphoid Vaccines

Identifiers

PMID35714648
PMCPMC9210262
OpenAlexW4282941572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.